Cormorant Asset Management, LP Harpoon Therapeutics, Inc. Transaction History

Cormorant Asset Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$13.81 - $23.25 $414,300 - $697,500	-30,000 Reduced 5.26%	540,600 $7.5 Million
Q3 2020 Nov 16, 2020	SELL	$11.01 - $18.52 $821,973 - $1.38 Million	-74,657 Reduced 11.57%	570,600 $9.69 Million
Q2 2020 Aug 14, 2020	SELL	$11.11 - $24.72 $52,616 - $117,073	-4,736 Reduced 0.73%	645,257 $10.7 Million
Q1 2020 May 15, 2020	SELL	$10.74 - $16.32 $10 - $16	-1 Reduced -0.0%	649,993 $7.53 Million
Q2 2019 Aug 14, 2019	SELL	$10.0 - $13.03 $238,970 - $311,377	-23,897 Reduced 3.55%	649,994 $8.45 Million
Q1 2019 May 15, 2019	BUY	$9.47 - $17.01 $6.38 Million - $11.5 Million	673,891 New	673,891 $6.38 Million

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.